SUBSTITUTED NAPHTHYRIDINES AND USE THEREOF AS MEDICINES
    1.
    发明申请
    SUBSTITUTED NAPHTHYRIDINES AND USE THEREOF AS MEDICINES 审中-公开
    取代的萘啶酮及其作为药物的用途

    公开(公告)号:US20110201608A1

    公开(公告)日:2011-08-18

    申请号:US13057288

    申请日:2009-07-23

    摘要: The invention relates to new substituted naphthyridines of formula 1, as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof, wherein R1 denotes a group A selected from among —O—R3, —NR3R4, —CR3R4R5, -(ethyne)-R3, —S—R3, —SO—R3 and SO2—R3 or R1 denotes a group B selected from among C6-10-aryl, five- to ten-membered, mono- or bicyclic heteroaryl with 1-3 heteroatoms selected independently of one another from among N, O and S; while this heteroaryl is linked to the structure according to formula 1 via either a C atom or an N atom, three- to ten-membered, mono- or bicyclic, saturated or partially saturated heterocyclic group with 1-3 heteroatoms selected independently of one another from among N, O and S, while this heterocyclic group is linked to the structure according to formula 1 via either a C atom or an N atom, and 5- to 11-membered spiro group which may optionally contain 1, 2 or 3 heteroatoms selected independently of one another from among N, O and S, while this spiro group is linked to the structure according to formula 1 via either a C atom or an N atom, while this group B may optionally be substituted as described in claim 1 and wherein R2 is and R3, R4, R5, R6, R6′, R7, R8, R9, R10, V, n and m may have the meanings given in claim 1, as well as pharmaceutical compositions containing these compounds.

    摘要翻译: 本发明涉及式1的新取代的萘啶,以及其药学上可接受的盐,非对映异构体,对映异构体,外消旋体,水合物或溶剂化物,其中R1表示选自-O-R3,-NR3R4,-CR3R4R5, (乙炔)-R 3,-S-R 3,-SO-R 3和SO 2 -R 3或R 1表示选自C 6-10 - 芳基,5至10元,单 - 或双环杂芳基和1-3 从N,O和S中彼此独立地选择的杂原子; 而该杂芳基通过C原子或N原子连接到根据式1的结构,具有1-3个互相独立选择的杂原子的三至十元,单环或二环,饱和或部分饱和的杂环基 N,O和S中的至少一个,而该杂环基通过C原子或N原子与根据式1的结构连接,并且可以任选地含有1,2或3个杂原子的5至11元螺环 N,O和S彼此独立地选择,而该螺环通过C原子或N原子连接到根据式1的结构,而该基团B可以任选地被如权利要求1和 其中R2是和R3,R4,R5,R6,R6',R7,R8,R9,R10,V,n和m可以具有权利要求1中给出的含义,以及含有这些化合物的药物组合物。

    4-DIMETHYLAMINO-PHENYL-SUBSTITUTED NAPHTHYRIDINES, AND USE THEREOF AS MEDICAMENTS
    2.
    发明申请
    4-DIMETHYLAMINO-PHENYL-SUBSTITUTED NAPHTHYRIDINES, AND USE THEREOF AS MEDICAMENTS 有权
    4-二甲基苯胺基 - 取代的萘啶,并作为药物使用

    公开(公告)号:US20110263549A1

    公开(公告)日:2011-10-27

    申请号:US13057330

    申请日:2009-07-23

    CPC分类号: C07D471/04 C07D519/00

    摘要: The invention relates to novel substituted naphthyridines of formula 1 as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates, or solvates thereof. In formula 1, R1 can represent a group A selected from among the group comprising —O—R3, —NR3 R4, —CR3R4R5, -(ethyne)-R3, —S—R3, —SO—R3, and SO2—R3, or R1 represents a group B selected from among the group comprising: —C6-10-aryl;—a five-membered to ten-membered, monocyclic or bicyclic heteroaryl containing 1 to 3 heteroatoms independently selected from among the group comprising N, O, and S, wherein said heteroaryl is linked to the structure according to formula 1 via a C atom or an N atom;—a three-membered to ten-membered, monocyclic or bicyclic, saturated or partially saturated heterocycle containing 1 to 3 heteroatoms independently selected from among the group comprising N, O, and S, wherein said heterocycle is linked to the structure according to formula 1 via a C atom or an N atom; and—a 5-membered to 11-membered spiro group which can optionally contain 1, 2, or 3 heteroatoms independently selected from among the group comprising N, O, and S, wherein said spiro group is linked to the structure according to formula 1 via a C atom or an N atom, wherein said group B can be optionally substituted as described in claims 1, and R3,R4,R5,R6, and m can have the meanings indicated in claim 1. The invention also relates to pharmaceutical compositions containing said compounds.

    摘要翻译: 本发明涉及式1的新型取代萘啶以及其药理学上可接受的盐,非对映异构体,对映异构体,外消旋物,水合物或溶剂合物。 在式1中,R 1可以表示选自-O-R 3,-NR 3 R 4,-CR 3 R 4 R 5, - (乙炔)-R 3,-S-R 3,-SO-R 3和SO 2 -R 3的基团A, 或R 1表示选自包括以下基团的基团:-C 6-10 - 芳基; - 含有1至3个独立地选自以下的杂原子的五元至十元单环或双环杂芳基:N,O, 和S,其中所述杂芳基通过C原子或N原子连接到根据式1的结构; - 含有1至3个独立选择的杂原子的三元至十元单环或双环饱和或部分饱和的杂环 包括N,O和S的基团,其中所述杂环通过C原子或N原子连接到根据式1的结构; 和可以任选地含有1,2或3个独立地选自包括N,O和S的基团的杂原子的5元至11元螺环,其中所述螺环与根据式1的结构连接 通过C原子或N原子,其中所述基团B可以如权利要求1所述任选被取代,并且R 3,R 4,R 5,R 6和m可以具有权利要求1中所示的含义。本发明还涉及药物组合物 含有所述化合物。

    4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments
    4.
    发明授权
    4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments 有权
    4-二甲基氨基 - 苯基取代的萘啶,及其用作药物

    公开(公告)号:US08604049B2

    公开(公告)日:2013-12-10

    申请号:US13057330

    申请日:2009-07-23

    CPC分类号: C07D471/04 C07D519/00

    摘要: The invention relates to novel substituted naphthyridines of formula 1 as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates, or solvates thereof. In formula 1, R1 can represent a group A selected from among the group comprising —O—R3, —NR3R4, —CR3R4R5, -(ethyne)-R3, —S—R3, —SO—R3, and SO2—R3, or R1 represents a group B selected from among the group comprising: —C6-10-aryl; —a five-membered to ten-membered, monocyclic or bicyclic heteroaryl containing 1 to 3 heteroatoms independently selected from among the group comprising N, O, and S, wherein said heteroaryl is linked to the structure according to formula 1 via a C atom or an N atom; —a three-membered to ten-membered, monocyclic or bicyclic, saturated or partially saturated heterocycle containing 1 to 3 heteroatoms independently selected from among the group comprising N, O, and S, wherein said heterocycle is linked to the structure according to formula 1 via a C atom or an N atom; and —a 5-membered to 11-membered spiro group which can optionally contain 1, 2, or 3 heteroatoms independently selected from among the group comprising N, O, and S, wherein said spiro group is linked to the structure according to formula 1 via a C atom or an N atom, wherein said group B can be optionally substituted as described in claims 1, and R3, R4, R5, R6, and m can have the meanings indicated in claim 1. The invention also relates to pharmaceutical compositions containing said compounds.

    摘要翻译: 本发明涉及式1的新型取代萘啶以及其药理学上可接受的盐,非对映异构体,对映异构体,外消旋物,水合物或溶剂合物。 在式1中,R 1可以表示选自-O-R 3,-NR 3 R 4,-CR 3 R 4 R 5, - (乙炔)-R 3,-S-R 3,-SO-R 3和SO 2 -R 3的基团A,或 R 1表示选自以下的基团B:-C 6-10 - 芳基; 包含1至3个独立地选自N,O和S的杂原子的五元至十元单环或二环杂芳基,其中所述杂芳基通过C原子连接至根据式1的结构,或 一个N原子; 包含1-3个独立地选自包括N,O和S的杂原子的3至10元,单环或双环饱和或部分饱和的杂环,其中所述杂环与根据式1的结构连接 通过C原子或N原子; 和可以任选地含有1,2或3个独立地选自N,O和S的组的杂原子的5元至11元螺环,其中所述螺环与根据式1的结构连接 通过C原子或N原子,其中所述基团B可以如权利要求1所述任选被取代,并且R 3,R 4,R 5,R 6和m可以具有权利要求1中所示的含义。本发明还涉及药物组合物 含有所述化合物。

    Hand held electronic device with user controlled power saving feature
    5.
    发明授权
    Hand held electronic device with user controlled power saving feature 有权
    手持电子设备,具有用户控制的省电功能

    公开(公告)号:US08935554B2

    公开(公告)日:2015-01-13

    申请号:US13394592

    申请日:2010-08-25

    IPC分类号: G06F1/00 G06F1/16 G06F1/32

    摘要: An opening/closing detection unit detects a transition of an electronic device from an open state to a closed state or from the closed state to the open state. An electrical-power control unit sets an operation mode of an application processing unit that executes an application. When a transition from the open state to the closed state is detected while a hold switch is in an OFF state, the electrical-power control unit switches an operation mode of an application processing unit from a normal mode to a sleep mode. On the other hand, when a transition from the open state to the closed state is detected while the hold switch is in an ON state, the electrical-power control unit does not switch the operation mode of the application processing unit from the normal mode to the sleep mode.

    摘要翻译: 打开/关闭检测单元检测电子设备从打开状态到关闭状态或从关闭状态到打开状态的转变。 电力控制单元设置执行应用的应用处理单元的操作模式。 当保持开关处于OFF状态时,当检测到从打开状态到关闭状态的转变时,电力控制单元将应用处理单元的操作模式从正常模式切换到睡眠模式。 另一方面,当保持开关处于接通状态时,当检测到从打开状态到关闭状态的转变时,电力控制单元不将应用处理单元的操作模式从正常模式切换到 睡眠模式。

    Method of manufacturing copper electrode
    8.
    发明授权
    Method of manufacturing copper electrode 有权
    铜电极的制造方法

    公开(公告)号:US08647815B1

    公开(公告)日:2014-02-11

    申请号:US13558912

    申请日:2012-07-26

    IPC分类号: G03F7/26

    CPC分类号: C23C18/1216

    摘要: A method for manufacturing an electrode comprising the steps of: applying onto a substrate a conductive paste to form a conductive paste layer comprising; (i) 100 parts by weight of a copper powder coated with a metal oxide selected from the group consisting of silicon oxide (SiO2), zinc oxide (ZnO), aluminum oxide (Al2O3), titanium oxide (TiO2), magnesium oxide (MgO) and a mixture thereof; (ii) 5 to 30 parts by weight of a boron powder; and (iii) 0.1 to 10 parts by weight of a glass frit; dispersed in (iv) an organic vehicle; and firing the conductive paste in air.

    摘要翻译: 一种用于制造电极的方法,包括以下步骤:在基底上施加导电膏以形成导电浆料层,其包括: (i)100重量份涂覆有选自氧化硅(SiO 2),氧化锌(ZnO),氧化铝(Al 2 O 3),氧化钛(TiO 2),氧化镁(MgO) )及其混合物; (ii)5〜30重量份的硼粉末; 和(iii)0.1至10重量份的玻璃料; 分散在(iv)有机载体中; 并在空气中烧制导电膏。

    ELECTRONIC DEVICE
    9.
    发明申请
    ELECTRONIC DEVICE 有权
    电子设备

    公开(公告)号:US20120239955A1

    公开(公告)日:2012-09-20

    申请号:US13394592

    申请日:2010-08-25

    IPC分类号: G06F1/32 G06F1/16

    摘要: An opening/closing detection unit detects a transition of an electronic device from an open state to a closed state or from the closed state to the open state. An electrical-power control unit sets an operation mode of an application processing unit that executes an application. When a transition from the open state to the closed state is detected while a hold switch is in an OFF state, the electrical-power control unit switches an operation mode of an application processing unit from a normal mode to a sleep mode. On the other hand, when a transition from the open state to the closed state is detected while the hold switch is in an ON state, the electrical-power control unit does not switch the operation mode of the application processing unit from the normal mode to the sleep mode.

    摘要翻译: 打开/关闭检测单元检测电子设备从打开状态到关闭状态或从关闭状态到打开状态的转变。 电力控制单元设置执行应用的应用处理单元的操作模式。 当保持开关处于OFF状态时,当检测到从打开状态到关闭状态的转变时,电力控制单元将应用处理单元的操作模式从正常模式切换到睡眠模式。 另一方面,当保持开关处于接通状态时,当检测到从打开状态到关闭状态的转变时,电力控制单元不将应用处理单元的操作模式从正常模式切换到 睡眠模式。

    LSI system including a plurality of LSI circuit chips mounted on a board
    10.
    发明授权
    LSI system including a plurality of LSI circuit chips mounted on a board 失效
    LSI系统包括安装在板上的多个LSI电路芯片

    公开(公告)号:US4949033A

    公开(公告)日:1990-08-14

    申请号:US354364

    申请日:1989-05-19

    CPC分类号: G01R31/2818 G01R31/316

    摘要: An LSI system includes; a multi-layer print board; and a plurality of LSI circuit chips mounted on the multi-layer printed circuit board, each including a plurality of pins, a reference voltage terminal, a pin scan out terminal and a plurality of pin scan out circuits corresponding to the pins on a one-to-one basis. The multi-layer printed circuit board includes a reference voltage feeding layer formed therein in a form of a mesh or a sheet, at least one further layer overlying the reference voltage feeding layer and a plurality of through holes extending through each such further layer. By electrically connecting each reference voltage terminal of the plurality of LSI circuit chips through a corresponding through hole to the reference voltage feeding layer, a substantially equal reference voltage can be fed to each LSI and the voltage drop thereof is reduced.